NCT00553748View on ClinicalTrials.gov

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Brain Cancer
Interventions
DRUG

F-18 FLT

One - 10 mci dose of F-18 FLT is administered IV over about 5 seconds prior to PET imaging. Each imaging dose contains no more than 6.1 micrograms of FLT.

Trial Locations (1)

19107

Thomas Jefferson University Hospital, Philadelphia

All Listed Sponsors
lead

Siemens Molecular Imaging

INDUSTRY

NCT00553748 - Phase I, Open Label, Single Center Safety Study of [F-18]FLT | Biotech Hunter | Biotech Hunter